US FDA Creates Expedited Review For Military-Related Products
All 'top priority' battlefield products will get FDA review by June 30; longer term plan includes draft guidance on development of products designed for use in austere conditions.
You may also be interested in...
Congress wants HHS to explain why BARDA scientists were removed from leadership positions on COVID-19 vaccine contracts. It is just one of multiple examples of Democrats raising concerns that Operation Warp Speed could be hurting, not helping the COVID-19 response effort.
US FDA would have more influence in inter-agency turf battles, can build stronger relationships on Capitol Hill with a confirmed commissioner, Scott Gottlieb says.
US FDA Commissioner Gottlieb defended the decision to clear the controversial opioid in the agency’s press release on the approval, and announced a possible shift in how future opioid applications are reviewed.